Literature DB >> 2554059

Expression of insulin-like growth factor-II mRNA in fetal kidney and Wilms' tumor. An in situ hybridization study.

S Paik1, N Rosen, W Jung, J M You, M E Lippman, J F Perdue, D Yee.   

Abstract

The pattern of insulin-like growth factor II (IGF-II) mRNA expression in developing kidney and Wilms' tumor was examined with in situ hybridization. In developing kidney, IGF-II was primarily expressed in blastemal cells and lost with their differentiation. In triphasic Wilms' tumor, a similar relationship was found. But in a monomorphous Wilms', tumor cells with epithelial differentiation expressed IGF-II mRNA. These data suggest that IGF-II may be involved in fetal nephrogenesis, that its expression is inversely coupled to normal epithelial differentiation, and that this differentiation may be aberrantly regulated in Wilms' tumor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554059

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  11 in total

1.  IGF-II dependent autocrine growth in cell lines derived from renal tumours of childhood.

Authors:  W Zumkeller; A Mahmood; R Dellow; P N Schofield
Journal:  Clin Mol Pathol       Date:  1995-12

2.  SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor.

Authors:  Andrew J Murphy; Janene Pierce; Christian de Caestecker; Chase Taylor; James R Anderson; Alan O Perantoni; Mark P de Caestecker; Harold N Lovvorn
Journal:  J Pediatr Surg       Date:  2012-06       Impact factor: 2.545

3.  Detection of anti-sense transcripts of the insulin-like growth factor-2 gene in Wilms' tumor.

Authors:  P Baccarini; M Fiorentino; A D'Errico; A M Mancini; W F Grigioni
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

4.  A putative Wilms tumor-secreted growth factor activity required for primary culture of human nephroblasts.

Authors:  C R Burrow; P D Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

5.  Identification of the neurotrophin receptors p75 and trk in a series of Wilms' tumors.

Authors:  M J Donovan; B Hempstead; L J Huber; D Kaplan; P Tsoulfas; M Chao; L Parada; D Schofield
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

6.  Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product.

Authors:  H Werner; G G Re; I A Drummond; V P Sukhatme; F J Rauscher; D A Sens; A J Garvin; D LeRoith; C T Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

7.  The cell type-specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome.

Authors:  F Hedborg; L Holmgren; B Sandstedt; R Ohlsson
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

Review 8.  Insulin-like growth factor expression in breast cancer epithelium and stroma.

Authors:  K J Cullen; A Allison; I Martire; M Ellis; C Singer
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

9.  Expression of IGF-I and IGF-II mRNA in breast tissue.

Authors:  S Paik
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

10.  Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression.

Authors:  H Werner; Z Shen-Orr; F J Rauscher; J F Morris; C T Roberts; D LeRoith
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.